Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation

NCT: NCT07845682 · NOT_YET_RECRUITING

NCT IDNCT07845682
StatusNOT_YET_RECRUITING
Start Date2026-09-24
Completion2028-04-17
SponsorBiosense Webster, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This purpose of this study is to understand how safe Biosense Webster Pulsed Field (PF)/Radiofrequency (RF) ablation system is and how well it works over 12 months in participants with persistent atrial fibrillation (PsAF; abnormal heart signals that cause irregular heartbeats).

Frequently Asked Questions

What is A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation?

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation is a clinical trial registered under NCT07845682. Current status: NOT_YET_RECRUITING.

What is the status of NCT07845682?

The current status of NCT07845682 (A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation) is: NOT_YET_RECRUITING.

When did A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation start?

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation started on 2026-09-24.

Related Devices

PMA P210027Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationBiosense Webster, Inc. PMA P240006Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationBiosense Webster, Inc. PMA P010068catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBiosense Webster, Inc. PMA P030031catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBiosense Webster, Inc. K231312PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto IDBiosense Webster, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑